Annual Working Capital
$143.86 M
-$98.68 M-40.69%
December 31, 2023
Summary
- As of February 7, 2025, CHRS annual working capital is $143.86 million, with the most recent change of -$98.68 million (-40.69%) on December 31, 2023.
- During the last 3 years, CHRS annual working capital has fallen by -$477.97 million (-76.86%).
- CHRS annual working capital is now -76.86% below its all-time high of $621.83 million, reached on December 31, 2020.
Performance
CHRS Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$73.46 M
-$21.47 M-22.62%
September 30, 2024
Summary
- As of February 7, 2025, CHRS quarterly working capital is $73.46 million, with the most recent change of -$21.47 million (-22.62%) on September 30, 2024.
- Over the past year, CHRS quarterly working capital has dropped by -$131.25 million (-64.12%).
- CHRS quarterly working capital is now -88.19% below its all-time high of $621.83 million, reached on December 31, 2020.
Performance
CHRS Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
CHRS Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -40.7% | -64.1% |
| 3 y3 years | -76.9% | -66.0% |
| 5 y5 years | +181.1% | -66.0% |
CHRS Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -67.1% | at low | -83.2% | at low |
| 5 y | 5-year | -76.9% | at low | -88.2% | at low |
| alltime | all time | -76.9% | +1892.9% | -88.2% | +1015.5% |
Coherus BioSciences Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $73.46 M(-22.6%) |
| Jun 2024 | - | $94.93 M(+6.5%) |
| Mar 2024 | - | $89.17 M(-38.0%) |
| Dec 2023 | $143.86 M(-40.7%) | $143.86 M(-29.7%) |
| Sep 2023 | - | $204.71 M(-5.2%) |
| Jun 2023 | - | $216.04 M(+12.2%) |
| Mar 2023 | - | $192.52 M(-20.6%) |
| Dec 2022 | $242.54 M(-44.5%) | $242.54 M(-12.4%) |
| Sep 2022 | - | $276.96 M(-9.5%) |
| Jun 2022 | - | $306.03 M(-14.7%) |
| Mar 2022 | - | $358.69 M(-17.9%) |
| Dec 2021 | $437.00 M(-29.7%) | $437.00 M(+23.9%) |
| Sep 2021 | - | $352.69 M(-5.4%) |
| Jun 2021 | - | $372.96 M(+3.7%) |
| Mar 2021 | - | $359.66 M(-42.2%) |
| Dec 2020 | $621.83 M(+172.7%) | $621.83 M(+4.8%) |
| Sep 2020 | - | $593.49 M(+8.7%) |
| Jun 2020 | - | $546.10 M(+97.7%) |
| Mar 2020 | - | $276.17 M(+21.1%) |
| Dec 2019 | $228.04 M | $228.04 M(+17.7%) |
| Sep 2019 | - | $193.67 M(+34.1%) |
| Jun 2019 | - | $144.40 M(+22.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $117.75 M(+130.1%) |
| Dec 2018 | $51.17 M(-56.3%) | $51.17 M(-51.6%) |
| Sep 2018 | - | $105.78 M(-29.8%) |
| Jun 2018 | - | $150.58 M(+78.0%) |
| Mar 2018 | - | $84.62 M(-27.7%) |
| Dec 2017 | $117.08 M(+11.4%) | $117.08 M(-16.5%) |
| Sep 2017 | - | $140.18 M(+19.4%) |
| Jun 2017 | - | $117.39 M(-27.1%) |
| Mar 2017 | - | $160.96 M(+53.1%) |
| Dec 2016 | $105.11 M(+15.0%) | $105.11 M(-11.6%) |
| Sep 2016 | - | $118.93 M(-7.5%) |
| Jun 2016 | - | $128.55 M(+8.3%) |
| Mar 2016 | - | $118.66 M(+29.9%) |
| Dec 2015 | $91.37 M(-28.3%) | $91.37 M(-14.4%) |
| Sep 2015 | - | $106.78 M(-37.1%) |
| Jun 2015 | - | $169.65 M(+84.4%) |
| Mar 2015 | - | $91.98 M(-27.8%) |
| Dec 2014 | $127.35 M(-1687.2%) | $127.35 M(+79.9%) |
| Sep 2014 | - | $70.80 M(+0.9%) |
| Jun 2014 | - | $70.14 M(-974.2%) |
| Dec 2013 | -$8.02 M(-159.2%) | -$8.02 M |
| Dec 2012 | $13.55 M | - |
FAQ
- What is Coherus BioSciences annual working capital?
- What is the all time high annual working capital for Coherus BioSciences?
- What is Coherus BioSciences annual working capital year-on-year change?
- What is Coherus BioSciences quarterly working capital?
- What is the all time high quarterly working capital for Coherus BioSciences?
- What is Coherus BioSciences quarterly working capital year-on-year change?
What is Coherus BioSciences annual working capital?
The current annual working capital of CHRS is $143.86 M
What is the all time high annual working capital for Coherus BioSciences?
Coherus BioSciences all-time high annual working capital is $621.83 M
What is Coherus BioSciences annual working capital year-on-year change?
Over the past year, CHRS annual working capital has changed by -$98.68 M (-40.69%)
What is Coherus BioSciences quarterly working capital?
The current quarterly working capital of CHRS is $73.46 M
What is the all time high quarterly working capital for Coherus BioSciences?
Coherus BioSciences all-time high quarterly working capital is $621.83 M
What is Coherus BioSciences quarterly working capital year-on-year change?
Over the past year, CHRS quarterly working capital has changed by -$131.25 M (-64.12%)